Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-alpha therapy

被引：5
|
作者：
Musset, L
Ghillani, P
Lunel, F
Cacoub, P
Cresta, P
Frangeul, L
Rosenheim, M
Preudhomme, JL
机构：
[1] GRP HOSP PITIE SALPETRIERE,VIROL LAB,F-75651 PARIS 13,FRANCE
[2] GRP HOSP PITIE SALPETRIERE,DEPT HEPATOGASTROENTEROL,F-75651 PARIS 13,FRANCE
[3] GRP HOSP PITIE SALPETRIERE,DEPT INTERNAL MED,F-75651 PARIS 13,FRANCE
[4] GRP HOSP PITIE SALPETRIERE,PUBL HLTH UNIT,F-75651 PARIS 13,FRANCE
[5] UNIV POITIERS HOSP,LAB IMMUNOL & IMMUNOPATHOL,CNRS URA 1172,POITIERS,FRANCE
来源：
IMMUNOLOGY LETTERS | 1997年 / 55卷 / 01期
关键词：
hepatitis C virus; IgG subclass; interferon-alpha;
D O I：
10.1016/S0165-2478(96)02681-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Serum IgG1 levels are selectively increased in patients with chronic hepatitis C virus (HCV) infection. In 15 patients who received interferon (IFN)-alpha therapy, serum levels of immunoglobulin classes and IgG subclasses were measured during treatment and after it was discontinued. In spite of important individual variations, mean IgG, IgG1, IgA and IgM levels decreased during therapy and tended to return to pre-treatment levels afterwards, with no detectable correlation with clinical and biological parameters. These results suggest an effect of IFN-alpha on in vivo immunoglobulin production, in HCV carriers. (C) 1997 Elsevier Science B.V.
引用
收藏
页码：41 / 45
页数：5
相关论文
共 50 条
  • [21] SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTORS AND EFFECTS OF INTERFERON-ALPHA FOR PATIENTS WITH CHRONIC HEPATITIS-C VIRUS
    HAYASHI, J
    KISHIHARA, Y
    YAMAJI, K
    YOSHIMURA, E
    OHMIYA, M
    TANI, Y
    IKEMATSU, H
    KASHIWAGI, S
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (08) : 1837 - 1841
  • [22] Variations of hepatitis C virus NS5B sequence (nucleotides 8261-8566) do not correlate with response to interferon-alpha therapy
    Nelson, DR
    Gray, AH
    Kolberg, JA
    Joh, J
    Urdea, MS
    Mizokami, M
    Davis, GL
    Lau, JYN
    JOURNAL OF VIRAL HEPATITIS, 1995, 2 (06) : 285 - 292
  • [23] Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: Long-term response with maintenance therapy
    Singh, N
    Gayowski, T
    Wannstedt, CF
    Marino, IR
    Wagener, MM
    CLINICAL TRANSPLANTATION, 1996, 10 (04) : 348 - 351
  • [24] Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection
    Sarac, E
    Bastacky, S
    Johnson, JP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (01) : 113 - 115
  • [25] Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C
    Martinot, M
    Marcellin, P
    Boyer, N
    Detmer, J
    Pouteau, M
    Castelnau, C
    Degott, C
    Auperin, A
    Collins, M
    Kolberg, J
    Wilber, J
    Benhamou, JP
    Erlinger, S
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (11) : 874 - +
  • [26] Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction
    Obolonczyk, Lukasz
    Siekierska-Hellmann, Malgorzata
    Sworczak, Krzysztof
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2008, 62 : 309 - 321
  • [27] The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naive chronic hepatitis C patients
    Dai, CY
    Yu, ML
    Chuang, WL
    Hou, NJ
    Hou, C
    Chen, SC
    Lin, ZY
    Hsieh, MY
    Wang, LY
    Chang, WY
    ANTIVIRAL RESEARCH, 2002, 53 (01) : 9 - 18
  • [28] Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C - Relationship to genotypes of hepatitis C virus
    Izumi, N
    Enomoto, N
    Uchihara, M
    Murakami, T
    Ono, K
    Noguchi, O
    Miyake, S
    Nouchi, T
    Fujisawa, K
    Marumo, F
    Sato, C
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (05) : 989 - 994
  • [29] Pituitary Disease in Chronic Hepatitis C Infection and Interferon-alpha Related Therapy: Two Case Reports
    Tran, Huy A.
    Crock, Patricia A.
    Reeves, Glenn E. M.
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 2 (4-5) : 190 - 194
  • [30] TREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON-ALPHA - SUSTAINED ABSENCE OF HEPATITIS-C VIRUS-RNA FROM SERUM AFTER 4 COURSES OF THERAPY
    TOYODA, H
    NAKANO, S
    KUMADA, T
    TAKEDA, I
    SUGIYAMA, K
    OSADA, T
    KIRIYAMA, S
    TAKAHASHI, M
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1995, 23 (04) : 308 - 314
12345